{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:04:10Z","timestamp":1789718650265,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T00:00:00Z","timestamp":1456358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00415-016-8050-2","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T08:56:59Z","timestamp":1456390619000},"page":"772-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia"],"prefix":"10.1007","volume":"263","author":[{"given":"Yi","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Dashtipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"8050_CR1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/9781841848525.010","volume-title":"Handbook of dystonia","author":"K Dashtipour","year":"2012","unstructured":"Dashtipour K, Lew M (2012) Cervical dystonia. In: Stacy M (ed) Handbook of dystonia, 2nd edn. CRC Press, Boca Raton, pp 144\u2013158","edition":"2"},{"key":"8050_CR2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.41.7.1088","volume":"41","author":"J Jankovic","year":"1991","unstructured":"Jankovic J, Leder S, Warner D, Schwartz K (1991) Cervical dystonia: clinical findings and associated movement disorders. Neurology 41:1088. doi: 10.1212\/WNL.41.7.1088","journal-title":"Neurology"},{"key":"8050_CR3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s004150070094","volume":"247","author":"ESDE","year":"2000","unstructured":"ESDE (2000) A prevalence study of primary dystonia in eight European countries. J Neurol 247:787\u2013792","journal-title":"J Neurol"},{"key":"8050_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.parkreldis.2007.02.005","volume":"13","author":"J Jankovic","year":"2007","unstructured":"Jankovic J, Tsui J, Bergeron C (2007) Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat Disord 13:411\u2013416. doi: 10.1016\/j.parkreldis.2007.02.005","journal-title":"Parkinsonism Relat Disord"},{"key":"8050_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","volume":"3","author":"JG Nutt","year":"1988","unstructured":"Nutt JG, Muenter MD, Aronson A et al (1988) Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 3:188\u2013194. doi: 10.1002\/mds.870030302","journal-title":"Mov Disord"},{"key":"8050_CR6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.870100513","volume":"10","author":"DW Claypool","year":"1995","unstructured":"Claypool DW, Duane DD, Ilstrup DM, Melton LJ (1995) Epidemiology and outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota. Mov Disord 10:608\u2013614. doi: 10.1002\/mds.870100513","journal-title":"Mov Disord"},{"key":"8050_CR7","doi-asserted-by":"crossref","unstructured":"Defazio G, Jankovic J, Giel JL, Papapetropoulos S (2013) Descriptive epidemiology of cervical dystonia. Tremor and other hyperkinetic movements (New York, NY), 3. http\/\/tremorjournal.org\/article\/view\/193","DOI":"10.5334\/tohm.170"},{"key":"8050_CR8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/jnnp-2012-303608","volume":"84","author":"D Dressler","year":"2013","unstructured":"Dressler D, Paus S, Seitzinger A et al (2013) Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia. J Neurol Neurosurg Psychiatry 84:1014\u20131019. doi: 10.1136\/jnnp-2012-303608","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8050_CR9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","volume":"64","author":"R Benecke","year":"2005","unstructured":"Benecke R, Jost WH, Kanovsky P et al (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64:1949\u20131951. doi: 10.1212\/01.WNL.0000163767.99354.C3","journal-title":"Neurology"},{"key":"8050_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","volume":"308","author":"CL Comella","year":"2011","unstructured":"Comella CL, Jankovic J, Truong DD et al (2011) Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci 308:103\u2013109. doi: 10.1016\/j.jns.2011.05.041","journal-title":"J Neurol Sci"},{"key":"8050_CR11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.49.3.701","volume":"49","author":"MF Lew","year":"1997","unstructured":"Lew MF, Adornato BT, Duane DD et al (1997) Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49:701\u2013707","journal-title":"Neurology"},{"key":"8050_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","volume":"20","author":"D Truong","year":"2005","unstructured":"Truong D, Duane DD, Jankovic J et al (2005) Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 20:783\u2013791. doi: 10.1002\/mds.20403","journal-title":"Mov Disord"},{"key":"8050_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A, Asmus F, Bhatia KP et al (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5\u201318. doi: 10.1111\/j.1468-1331.2010.03042.x","journal-title":"Eur J Neurol"},{"key":"8050_CR14","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Blitzer A, Brashear A et al (2008) Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699\u20131706. doi: 10.1212\/01.wnl.0000311389.26145.95","journal-title":"Neurology"},{"key":"8050_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03033933","volume":"9","author":"J Jankovic","year":"2006","unstructured":"Jankovic J (2006) Botulinum toxin therapy for cervical dystonia. Neurotox Res 9:145\u2013148. doi: 10.1007\/BF03033933","journal-title":"Neurotox Res"},{"key":"8050_CR16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","volume":"65","author":"CL Comella","year":"2005","unstructured":"Comella CL, Jankovic J, Shannon KM et al (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65:1423\u20131429. doi: 10.1212\/01.wnl.0000183055.81056.5c","journal-title":"Neurology"},{"key":"8050_CR17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.53.7.1439","volume":"53","author":"A Brashear","year":"1999","unstructured":"Brashear A, Lew M, Dykstra D (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A\u2013responsive cervical dystonia. Neurology 53:1439\u20131446","journal-title":"Neurology"},{"key":"8050_CR18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","volume":"53","author":"MF Brin","year":"1999","unstructured":"Brin MF, Lew MF, Adler CH et al (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53:1431\u20131438. doi: 10.1212\/WNL.53.7.1431","journal-title":"Neurology"},{"key":"8050_CR19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","volume":"23","author":"EEJ Pappert","year":"2008","unstructured":"Pappert EEJ, Germanson T (2008) Botulinum toxin type B vs. type A in toxin-na\u00efve patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mov Disord 23:510\u2013517. doi: 10.1002\/mds.21724","journal-title":"Mov Disord"},{"key":"8050_CR20","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1016\/j.jns.2013.07.402","volume":"333","author":"R Benecke","year":"2013","unstructured":"Benecke R, Hauschke D, Roggenk\u00e4mper P (2013) Incobotulinum\/INS;toxin\/INS;A demonstrated therapeutic equivalence to onabotulinum\/INS;toxin\/INS;A in the treatment of blepharospasm and cervical dystonia. J Neurol Sci 333:e120. doi: 10.1016\/j.jns.2013.07.402","journal-title":"J Neurol Sci"},{"key":"8050_CR21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-200767050-00003","volume":"67","author":"WH Jost","year":"2007","unstructured":"Jost WH, Blumel J, Grafe S (2007) Botulinum neurotoxin Type A free of complexing proteins (XEOMIN) in focal dystonia. Drugs 67:669\u2013683. doi: 10.2165\/00003495-200767050-00003","journal-title":"Drugs"},{"key":"8050_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNF.0b013e3181c46f48","volume":"33","author":"EMAB Quagliato","year":"2010","unstructured":"Quagliato EMAB, Carelli EF, Viana MA (2010) A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia. Clin Neuropharmacol 33:22\u201326. doi: 10.1097\/WNF.0b013e3181c46f48","journal-title":"Clin Neuropharmacol"},{"key":"8050_CR23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1524-4733.2008.00347.x","volume":"11","author":"JP Jansen","year":"2008","unstructured":"Jansen JP, Crawford B, Bergman G, Stam W (2008) Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 11:956\u2013964. doi: 10.1111\/j.1524-4733.2008.00347.x","journal-title":"Value Health"},{"key":"8050_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0272989X9001000104","volume":"10","author":"DM Eddy","year":"1990","unstructured":"Eddy DM, Hasselblad V, Shachter R (1990) An introduction to a bayesian method for meta-analysis: the confidence profile method. Med Decis Mak 10:15\u201323. doi: 10.1177\/0272989X9001000104","journal-title":"Med Decis Mak"},{"key":"8050_CR25","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1002\/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0","volume":"15","author":"JP Higgins","year":"1996","unstructured":"Higgins JP, Whitehead A (1996) Borrowing strength from external trials in a meta-analysis. Stat Med 15:2733\u20132749. doi: 10.1002\/(SICI)1097-0258(19961230)15:24<2733:AID-SIM562>3.0.CO;2-0","journal-title":"Stat Med"},{"key":"8050_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0272989X9801800110","volume":"18","author":"V Hasselblad","year":"1998","unstructured":"Hasselblad V (1998) Meta-analysis of multitreatment studies. Med Decis Mak 18:37\u201343. doi: 10.1177\/0272989X9801800110","journal-title":"Med Decis Mak"},{"key":"8050_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/01621459.1999.10473815","volume":"94","author":"F Dominici","year":"1999","unstructured":"Dominici F, Parmigiani G, Wolpert RL, Hasselblad V (1999) Meta-analysis of migraine headache treatments: combining information from heterogeneous designs. J Am Stat Assoc 94:16","journal-title":"J Am Stat Assoc"},{"key":"8050_CR28","volume-title":"Modeling in medical decision making : a Bayesian approach","author":"G Parmigiani","year":"2002","unstructured":"Parmigiani G (2002) Modeling in medical decision making : a Bayesian approach. Wiley, Chichester"},{"key":"8050_CR29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/mds.870120414","volume":"12","author":"CL Comella","year":"1997","unstructured":"Comella CL, Stebbins GT, Goetz CG et al (1997) Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 12:570\u2013575. doi: 10.1002\/mds.870120414","journal-title":"Mov Disord"},{"issue":"3","key":"8050_CR30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-012-0887-7","volume":"120","author":"WH Jost","year":"2013","unstructured":"Jost WH, Hefter H, Stenner A et al (2013) Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy. J Neural Transm 120(3):487\u2013496. http:\/\/doi.org\/10.1007\/s00702-012-0887-7 . Accessed 26 Jan 2016","journal-title":"J Neural Transm"},{"issue":"13","key":"8050_CR31","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","volume":"28","author":"J Ramirez-Castaneda","year":"2013","unstructured":"Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z (2013) Diffusion, spread, and migration of botulinum toxin. Mov Disord 28(13):1775\u20131783","journal-title":"Mov Disord"},{"key":"8050_CR32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/phar.1196","volume":"33","author":"JJ Chen","year":"2013","unstructured":"Chen JJ, Dashtipour K (2013) Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Pharmacotherapy 33:304\u2013318. doi: 10.1002\/phar.1196","journal-title":"Pharmacotherapy"},{"key":"8050_CR33","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/mds.25582","volume":"28","author":"J Ramirez-Castaneda","year":"2013","unstructured":"Ramirez-Castaneda J, Jankovic J, Comella C et al (2013) Diffusion, spread, and migration of botulinum toxin. Mov Disord 28:1775\u20131783. doi: 10.1002\/mds.25582","journal-title":"Mov Disord"},{"key":"8050_CR34","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","volume":"23","author":"G Lu","year":"2004","unstructured":"Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105\u20133124. doi: 10.1002\/sim.1875","journal-title":"Stat Med"},{"key":"8050_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200624010-00001","volume":"24","author":"AE Ades","year":"2006","unstructured":"Ades AE, Sculpher M, Sutton A et al (2006) Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 24:1\u201319. doi: 10.2165\/00019053-200624010-00001","journal-title":"Pharmacoeconomics"},{"key":"8050_CR36","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. doi: 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"8050_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. doi: 10.1186\/1471-2288-5-13","journal-title":"BMC Med Res Methodol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8050-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8050-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T03:48:17Z","timestamp":1654400897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8050-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,25]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["8050"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8050-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,25]]}}}